About Us-Hecin Scientific,Inc.

About Us

Founded in 2015, Hecin Scientific, Inc.(Hecin) is specialized in diagnosis solution for respiratory healthcare and scientific research. Located in the IUR( Industry-university-Research ) Base of the State Key Laboratory of Respiratory Diseases, we are dedicate to the innovative research and development on a variety of infection diagnosis, and have developed the largest respiratory biobank in China and a self-owned Biosafety Level P2 Laboratory, serving as a professional supplier of diagnostic reagents; rapid PCR instruments; PCR reference panel and molecular enzymes. With the mission of safeguarding human respiratory health, Hecin strives to independent research and development for making in-vitro diagnosis more accurate, more sensitive, more convenient and faster for clinicians. Committed to be a comprehensive diagnostic provider, our aim is to promote a healthy respiratory system for all.

2015 year

Establish in

600 +

Example of virus strain

80 Million

Sales

50 +

Contries

Our Mission

Ensuring human respiratory health

Our Vision

Comprehensive provider of diagnostic solution for respiratory diseases

Our Value

Pursuing excellence, technology-oriented, honest and trustworthy, embrace responsibility with passion

Our Mission

Ensuring human respiratory health

Our Vision

Comprehensive provider of diagnostic solution for respiratory diseases

Our Value

Pursuing excellence, technology-oriented, honest and trustworthy, embrace responsibility with passion

Honors

With a mission is to ensure human respiratory health

GDMPA High and new technology enterprises Trade organization member Competition award certificate

GDMPA 2020 Guangdong Quality credit Class A medical device manufacturer

GDMPA 2021 Guangdong Quality credit Class A medical device manufacturer

2022 Guangdong Quality credit Class A medical device manufacturer

Our market

Comprehensive respiratory infection diagnostic solution provider

Hecin products have reached to more than 70 countries and regions and affected by the COVID-19, the demand of respiratory diagnosis will surely keep continous increasing in the next 3-5 years all over the world.

Europe Asia Africa North America Oceania South America

Europe

Spain, Italy, Hungary, Portugal, Switzerland, Germany, Poland, Kosovo, Morocco, Netherlands, Denmark, Lithuania, Ukraine, Czech Republic, Austria, Belgium, Luxembourg, Monaco, Serbia, Slovenia, Croatia, Russia

Europe

Spain, Italy, Hungary, Portugal, Switzerland, Germany, Poland, Kosovo, Morocco, Netherlands, Denmark, Lithuania, Ukraine, Czech Republic, Austria, Belgium, Luxembourg, Monaco, Serbia, Slovenia, Croatia, Russia

Asia

Japan, Türkiye, Indonesia, Philippines, Thailand, Singapore, Pakistan, India, Bangladesh, Malaysia, Saudi Arabia

Africa

South Africa, Tanzania, Togo, Kenya, Tunisia, Algeria

North America

Canada, Dominica, Mexico, Guatemala

Oceania

Tonga, Australia

South America

Brazil, Colombia, Ecuador, Peru, Bolivia, Chile, Uruguay, Venezuela, Paraguay